Daunoxome should be diluted with 5% dextrose for infusion before administration. The recommended concentration after dilution is between 0. 2mg and 1mg daunorubicin/ml of solution. Daunoxome should be administered by intravenous infusion.

Daunoxome must not be given by the intramuscular or subcutaneous route or as a bolus injection. Daunoxome is a liposomal preparation and should not be used interchangeably with conventional รขโ‚ฌยฆ Before use, daunoxome will first be diluted with a solution of glucose (5%), and it will then be administered as an infusion into a vein (intravenously). Normally, daunoxome should be used รขโ‚ฌยฆ Daunoxome dosage and administration daunoxome should be administered intravenously over a 60 minute period at a dose of 40 mg/m 2, with doses repeated every two weeks. This chapter reviews the chemistry, clinical pharmacokinetics, efficacy, and safety and tolerability of daunoxome. Daunoxome represents a significant advance in drug delivery for the selective รขโ‚ฌยฆ

Daunoxome dosage and administration daunoxome should be administered intravenously over a 60 minute period at a dose of 40 mg/m 2, with doses repeated every two weeks. This chapter reviews the chemistry, clinical pharmacokinetics, efficacy, and safety and tolerability of daunoxome. Daunoxome represents a significant advance in drug delivery for the selective รขโ‚ฌยฆ Daunoxome should be administered intravenously over a 60 minute period at a dose of 40 mg/m2, with doses repeated every two weeks. Blood counts should be repeated prior to each dose, and therapy รขโ‚ฌยฆ Daunoxome should be administered intravenously over a minimum period of 30-60 minutes (see also sections 6. 2, 6. 3 and 6. 6. ). Daunoxome must not be given by the intramuscular or subcutaneous รขโ‚ฌยฆ Daunoxome should be diluted 1:1 with 5% dextrose injection (d5w) before administration. Each vial of daunoxome contains daunorubicin citrate equivalent to 50 mg daunorubicin base, at a concentration รขโ‚ฌยฆ

Daunoxome should be administered intravenously over a minimum period of 30-60 minutes (see also sections 6. 2, 6. 3 and 6. 6. ). Daunoxome must not be given by the intramuscular or subcutaneous รขโ‚ฌยฆ Daunoxome should be diluted 1:1 with 5% dextrose injection (d5w) before administration. Each vial of daunoxome contains daunorubicin citrate equivalent to 50 mg daunorubicin base, at a concentration รขโ‚ฌยฆ